Aug 11, 2021 4:30pm EDT DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2021 Financial Results
Aug 05, 2021 8:12am EDT DiaMedica Therapeutics to Report Second Quarter 2021 Financial Results and Provide a Business Update August 12, 2021
Jul 28, 2021 4:28pm EDT DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
Jul 15, 2021 4:15pm EDT DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors
Jun 29, 2021 6:58am EDT DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKD
May 17, 2021 8:54am EDT DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke
May 05, 2021 4:28pm EDT DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
Apr 28, 2021 4:04pm EDT DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021
Apr 22, 2021 8:16am EDT DiaMedica Therapeutics to Participate in the B. Riley Securities’ Neuroscience Conference
Apr 05, 2021 8:14am EDT DiaMedica Therapeutics to Present Research at the National Kidney Foundation’s 2021 Spring Clinical Meetings
